Matthew O'Brien's Stock Ratings

Piper Sandler Analyst

Matthew O'Brien is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/01/2024

Overall Average Return

8.84%

Smart Score

63.7%

Overall Average Return Percentile

59th

Number of Ratings

15
Buy NowGet Alert
07/01/2024ZBHBuy Now
Zimmer Biomet Holdings
$107.017.47%$140 → $115DowngradeOverweight → NeutralGet Alert
05/08/2024ATECBuy Now
Alphatec Holdings
$11.0054.55%$19 → $17MaintainsOverweightGet Alert
01/05/2023ZBHBuy Now
Zimmer Biomet Holdings
$107.0121.48%$120 → $130MaintainsNeutralGet Alert
08/02/2022ZBHBuy Now
Zimmer Biomet Holdings
$107.0112.14%$130 → $120MaintainsNeutralGet Alert
05/03/2022ZBHBuy Now
Zimmer Biomet Holdings
$107.0121.48%$110 → $130MaintainsNeutralGet Alert
03/14/2022SPNEBuy Now
SeaSpine Holdings
$28 → $21MaintainsOverweightGet Alert
03/02/2022ATECBuy Now
Alphatec Holdings
$11.0054.55%$22 → $17MaintainsOverweightGet Alert
02/24/2022PODDBuy Now
Insulet
$201.8013.97%$295 → $230MaintainsNeutralGet Alert
02/07/2022ZBHBuy Now
Zimmer Biomet Holdings
$107.012.79%$135 → $110MaintainsNeutralGet Alert
01/08/2021ZBHBuy Now
Zimmer Biomet Holdings
$107.0172.88%$160 → $185MaintainsOverweightGet Alert
11/05/2020ZBHBuy Now
Zimmer Biomet Holdings
$107.0149.52% → $160MaintainsOverweightGet Alert
09/21/2020ZBHBuy Now
Zimmer Biomet Holdings
$107.0149.52% → $160MaintainsOverweightGet Alert
08/04/2020ZBHBuy Now
Zimmer Biomet Holdings
$107.0149.52% → $160MaintainsOverweightGet Alert
05/11/2020ZBHBuy Now
Zimmer Biomet Holdings
$107.0149.52%$175 → $160MaintainsOverweightGet Alert
03/12/2018MOTSBuy Now
Motus GI Hldgs
$0.0611108.97% → $2100Initiates → OverweightGet Alert